News Articles for Liz Dallimore

Argenica uses Oxford AI spinoff for stroke evaluation

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based Argenica Therapeutics has partnered with an Oxford University AI spinout to evaluate the effectiveness of its flagship ARG-007 stroke drug, finding previously hidden impacts.

Perth pharma companies share in $12m

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Three Perth pharmaceutical companies will take a share of a $12 million funding injection by the federal government to develop Australian-made heart disease and diabetes treatments.Announced by

Argenica knocked back by US FDA

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based neurological drug developer Argenica Therapeutics has been knocked back by the US Food and Drug Administration, dashing hopes its US clinical trials would soon start.

Argenica taps investors for $12m

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Shares in Argenica Therapeutics were down by 13 per cent on Friday morning, despite the biotechnology technology announcing it would raise $12 million in order to complete its second phase trial of its ARG 007 drug in ischaemic stroke patients.

Perth biotech’s stroke drug in nationwide trial

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth biotech company Argenica Therapeutics' drug, which is designed to reduce brain tissue death following a stroke, will be administrated at two local hospitals in a nationwide trial.

Funding boost for WA health projects

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The state government has awarded $4.3 million to nine health and medical projects, including developing new therapy for liver cancer and delaying Alzheimer's disease progression.

Healthtech banks on rising numbers

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The commercial side of life sciences may have reached a critical mass in WA.

Appointments September 30, 2022

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our weekly appointments wrap includes Lauren Major, Sean-Paul Stephens, Michael Lundberg, Ashwin Nair, Tom Chaney, David Cresp, Addy Wetzler, Alex Maund, Esme Bowen and Liz Dallimore.

Board Moves April 4, 2022

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Liz Dallimore, Errol Turner, Michael Jordon, Melissa Chapman, Catherine Grant-Edwards, Neil Hutchison, Steve Brockhurst, Karen O'Neill, Darryl Abotomey, Joe D'Addio, Kelly Moore, Jason Livingstone, Trevor Matthews, Bill McKenzie, Dougal Ferguson, and Sylvia Moss.

Appointments June 25, 2021

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our weekly appointment wrap includes Alex Jenkins, Natalie Sarich-Dayton, Nick O'Loughlin, Kathryn Penno, Martina Ellis and Jerome Lee.

Perth biotech has strong start to trading

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

A Perron Institute spinout focused on reducing brain damage caused by strokes listed on the ASX this morning, with its share price rising 50 per cent.

Big data, big potential, big challenges

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

How should WA prepare for a productivity revolution driven by data science and machine learning?